Grantham, Mayo, Van Otterloo & Co (GMO)’s Axalta AXTA Stock Holding History
Bought
Maintained
Sold
Other funds holding AXTA
SCM
RC
CB
Grantham, Mayo, Van Otterloo & Co (GMO)'s AXTA Position: Q2 2020 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Axalta (AXTA) in Q2 2020, closing a stake of 1,532,501 shares — an estimated $26.5M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AXTA in Q4 2019 and held it in 2 quarters. The position peaked at $26.5M in Q1 2020. 310 funds tracked by Wall St. Rank hold AXTA as of Q2 2020.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Axalta position as of Q2 2020 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,532,501 Axalta shares in Q2 2020, an estimated $26.5M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Axalta in Q4 2019 and held it in 2 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Axalta position peaked at $26.5M in Q1 2020.
- 310 funds tracked by Wall St. Rank held Axalta as of Q2 2020.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.